Article
Prevalence of cancer-related cognitive impairment in pediatric patients and survivors of non-CNS cancers: A systematic review and meta-analysis
2025-01-24
Abstract excerpt
<h4>Background</h4> Neurocognitive toxicity is a common sequela of cancer and its treatment, with 40-60% of childhood cancer survivors experiencing cancer-related cognitive impairment (CRCI) following cancer and its treatment. CNS cancers and CNS-directed therapy are considered to pose the greatest risk; however, such impairment has also been reported in non-CNS cancers, the most commonly diagnosed in children. D...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d4a14885-c0f7-5fde-a669-68e9eb383fa3
- DOI
- 10.1101/2025.01.22.25320991
